Superselective neck dissection after chemoradiation: Feasibility based on clinical and pathologic comparisons

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 5, 2007, Pages 486-489

  Robbins, K Thomas ^a   Shannon, Kerwin ^b   Vieira, Francisco ^c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CANCER INSTITUTE NSW   (Australia)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CERVICAL LYMPHADENOPATHY; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX; LARYNX; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MOUTH CAVITY; NECK DISSECTION; OROPHARYNX; RADIATION DOSE; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE;

EID: 34249021714     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.5.486     Document Type: Review

References (12)

1. Bourhis J, Amand C, Pignon JP; MACH-NC Collaborative Group. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemotherapy. J Clin Oncol. 2004;22(suppl):489s.
2. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg. 2005;131:965-969.
3. Robbins KT, Kumar P, Wong FSH, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000;22:687-693.
4. Jesse RH, Ballantyne AJ, Larson D. Radical or modified neck dissection: a therapeutic dilemma. Am J Surg. 1978;136:516-519.
5. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg. 1988;10:160-167.
6. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29:1446-1449.
7. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405-409.
8. Robbins KT, Wong FS, Kumar P, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125:670-675.
9. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg. 2000;126:950-956.
10. Robbins KT, Ferlito A, Suárez C, et al. Is there a role for selective neck dissection after chemoradiation for head and neck cancer? J Am Coll Surg. 2004;199:913-916.
11. Andrade RS, Heron DE, Degirmenci B, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65:1315-1322.
12. Kutler DI, Wong RJ, Schoder H, Kraus DH. The current status of positronemission tomography scanning in the evaluation and follow-up of patients with head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2006;14:73-81.